SG Americas Securities’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
MCM
AWA
KCM
SG Americas Securities's IHE Position: Q3 2018 in Review
SG Americas Securities sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2018, closing a stake of 8,925 shares — an estimated $450K sold.
SG Americas Securities first reported a position in IHE in Q3 2013 and held it in 18 quarters. The position peaked at $3.29M in Q1 2015. 98 funds tracked by Wall St. Rank hold IHE as of Q3 2018.
- SG Americas Securities reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2018 after selling out during the quarter.
- SG Americas Securities sold 8,925 iShares US Pharmaceuticals ETF shares in Q3 2018, an estimated $450K.
- SG Americas Securities first reported a position in iShares US Pharmaceuticals ETF in Q3 2013 and held it in 18 quarters.
- SG Americas Securities's iShares US Pharmaceuticals ETF position peaked at $3.29M in Q1 2015.
- 98 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2018.
Based on SG Americas Securities's 13F filing for Q3 2018, filed 6 Nov 2018.